NorthStar Medical Radioisotopes received approval from the U.S. Food and Drug Administration (FDA) the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Columbia, Mo., the company announced…

NorthStar Medical Radioisotopes and Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, have signed a letter of intent for the commercial supply of copper-67 as an…

NorthStar Medical Radioisotopes and Purdue University’s College of Pharmacy signed a collaborative agreement, which expands the College of Pharmacy’s nuclear pharmacy training program, the company announced recently. “We are excited…

NorthStar Medical Radioisotopes has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…

NorthStar Medical Technologies has closed $100 million in secured financing, the company announced recently. According to a release, the funds were managed by Oberland Capital Management, and the money will…